What instructions should a nurse follow to initiate magnesium sulfate (MgSO4) infusion for fetal neuroprotection in a pregnant patient at 24–34 weeks gestation with imminent delivery?

Magnesium Sulfate Administration for Fetal Neuroprotection

Administer MgSO4 as a 4 g IV loading dose over 20-30 minutes, followed by a 1 g/hour continuous infusion until delivery (maximum 12-24 hours), when delivery is anticipated before 32 weeks gestation. 1

Patient Eligibility Criteria

Initiate MgSO4 for fetal neuroprotection when:

• Gestational age ≤31+6 weeks (some guidelines extend to <34 weeks) 1, 2
• Imminent delivery expected within 24 hours, defined by:
  • Active labor with cervical dilation ≥4 cm, OR
  • Planned preterm delivery for maternal/fetal indications, OR
  • Preterm premature rupture of membranes with anticipated delivery 3

Dosing Protocol

Loading Dose

• 4 g magnesium sulfate IV over 20-30 minutes 4, 3
• Dilute in 250 mL of 5% Dextrose or 0.9% Normal Saline
• IV route is preferred over IM due to more predictable serum levels 5

Maintenance Dose

• 1 g/hour continuous IV infusion 4, 3
• Continue until delivery occurs
• Maximum duration: 12-24 hours (professional consensus favors 12 hours to avoid cumulative doses >50 g) 5
• Discontinue if delivery no longer imminent after 12 hours 6

Alternative Regimen (if IV access limited)

• IM loading: 5 g (10 mL of 50% solution) in each buttock (total 10 g)
• IM maintenance: 5 g every 4 hours in alternate buttocks 1

Critical Monitoring Requirements

Before Each Dose

• Patellar reflex (knee jerk) must be present - absence indicates magnesium toxicity 4
• Respiratory rate ≥16 breaths/minute 4
• Urine output ≥100 mL in preceding 4 hours 4

During Infusion

• Vital signs every 15-30 minutes during loading dose
• Hourly vital signs during maintenance
• Continuous pulse oximetry
• Hourly urine output monitoring

Therapeutic Serum Levels

• Target: 3-6 mg/dL (2.5-5 mEq/L) for neuroprotection 4
• Reflexes diminish at >4 mEq/L
• Respiratory paralysis risk at 10 mEq/L 4

Contraindications and Precautions

Absolute Contraindications

• Myasthenia gravis
• Heart block
• Renal failure (reduce maximum dose to 20 g/48 hours) 4

Critical Safety Measures

• Have 10% calcium gluconate (1 g = 10 mL) at bedside as antidote for magnesium toxicity 4
• If reflexes absent or respiratory depression occurs: STOP infusion immediately and give calcium gluconate 1 g IV over 3 minutes 4

Maternal Side Effects to Monitor

• Flushing, warmth (common, benign)
• Nausea
• Muscle weakness
• Hypotension (limit IV fluids to 60-80 mL/hour to prevent pulmonary edema) 1

Duration Considerations

Continue for 24 hours postpartum if delivery occurs - this remains standard despite some evidence suggesting shorter courses may suffice 1. The risk of postpartum eclampsia justifies this approach.

Do NOT continue beyond 5-7 days total - prolonged administration causes fetal skeletal demineralization, osteopenia, and fractures 4.

Key Clinical Pitfalls

1. Omission by medical team is the most common reason for non-administration (50% in one study) 6 - use checklists and protocols
2. Inadequate monitoring during loading dose is frequent 6 - assign dedicated nurse
3. Renal insufficiency dramatically increases toxicity risk - check creatinine, reduce dose accordingly 4
4. Drug interactions: Potentiates neuromuscular blockers and CNS depressants - adjust doses of concurrent medications 4

Documentation Requirements

Document in orders:

• Indication: "Fetal neuroprotection for imminent preterm delivery at [X] weeks"
• Loading dose: 4 g IV over 20-30 minutes
• Maintenance: 1 g/hour continuous infusion
• Maximum duration: 12-24 hours or until delivery
• Monitoring parameters: reflexes, respiratory rate, urine output hourly
• Stop criteria: absent reflexes, respiratory rate <16, oliguria
• Calcium gluconate 1 g at bedside

The evidence strongly supports this protocol reduces cerebral palsy by 40% (RR 0.60) and moderate-to-severe cerebral palsy by 29% (RR 0.71) when administered appropriately 3.